Clinical Trial Update: No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track [NA]

View source ↗

Summary

This clinical trial update indicates a study is currently recruiting to evaluate intracoronary tirofiban for no-reflow in patients with ST-elevation myocardial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Aggrastat (tirofiban)

Snippet

Sponsor: Kafrelsheikh University | Conditions: No-Reflow, STEMI | NA | Status: RECRUITING